Distinct cytogenetic alterations in squamous intraepithelial lesions of the cervix revealed by laser-assisted microdissection and comparative genomic hybridization

Cancer

Volumn 84, Issue 6, 1998, Pages 375-379

  Aubele, Michaela ^a   Zitzelsberger, Horst ^a,b   Schenck, Ulrich ^c   Walch, Axel ^a   Höfler, Heinz ^a,c   Werner, Martin ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chromosomal imbalances; Comparative genomic hybridization; Degenerate oligonucleotide primed polymerase chain reaction; Laser microdissection; Routine cervical smears

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CHROMOSOME ANALYSIS; CHROMOSOME MICRODISSECTION; CYTOGENETICS; CYTOLOGY; DISEASE CLASSIFICATION; DNA HYBRIDIZATION; DNA SEQUENCE; DYSPLASIA; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA IN SITU;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOME ABERRATIONS; DNA; DNA PRIMERS; FEMALE; HUMANS; LASERS; MICROMANIPULATION; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0032567513     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981225)84:6<375::AID-CNCR10>3.0.CO;2-1     Document Type: Article

References (22)

1. Mitchell MF, Hittelman WN, Hong WK, Lotan R, Schottenfeld D. The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers. Cancer Epidemiol Biomarkers Prev 1994;3:619-26.
2. Lieu D. The Papanicolaou smear: its value and limitations. J Fam Pract 1996;42:391-9.
3. Park TW, Richart RM, Sun XW, Wright TC. Association between papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J Natl Cancer Inst 1996;88: 355-8.
4. Saegusa M, Takano Y, Hashimura M, Shoji Y, Okayasu I. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer 1995;76:2297-303.
5. Zhang W-H, Coppleson M, Rose BR, Sorich EA, Nightingale BN, Thompson CH, et al. Papillomavirus and cervical cancer: a clinical and laboratory study. J Med Virol 1988;26:163-74.
6. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer 1995;61:13-22.
7. di Luca D, Costa S, Monini P, Rotola A, Terzano P, Savioli A, et al. Search for human papillomavirus, herpes simplex and c-myc oncogene in human genital tumors. Int J Cancer 1989;43:570-7.
8. Ter-Hamsel B, Smedts F, Kuijpers J, Jeunink M, Trimbos B, Ramaekers F. bcl-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma. J Pathol 1996;179:26-30.
9. Dellas A, Schultheiss E, Almendral AC, Torhorst J, Gudat F. Assessment of EGFR and TGF-alpha expression in relationship to HPV status and Ki-67 distribution in cervical intraepithelial neoplasms. Int J Cancer 1996;69:165-9.
10. Steinbeck RG, Heselmeyer KM, Moberger HB, Auer GU. The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma. Acta Oncol 1995;34:171-6.
11. Segers P, Haesen S, Castelain P, Amy JJ, deSutter P, vanDam P, et al. Study of numerical aberrations of chromosome 1 by fluorescent in situ hybridization and DNA content by densitometric analysis on (pre)-malignant cervical lesions. Histochem J 1995;27:24-34.
12. Heselmeyer K, Schröck E, duManoir S, Biegen H, Shah K, Steinbeck R, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996;93:479-84.
13. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258:818-21.
14. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A 1994;91:2156-60.
15. Isola JJ, Kallioniemi O-P, Chu LW, Fuqua SAW, Hilsenbeck SG, Osborne CK, et al. Genetic aberration? detected by comparative genomic hybridization predict outcome in nodenegative breast cancer. Am J Pathol 1995;147:905-11.
16. Becker I, Becker KF, Röhrl MH, Schütze K, Minkus G, Höfler H. Single-cell mutation analysis from stained histological slides. Lab Invest 1996;75:801-7.
17. Telenius H, Carter NC, Bebb CE, Nordenskjöld M, Ponder BAJ, Tunnacliffe A. Degenerative oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992;13:718-25.
18. Lehmann L, Greulich KM, Zitzelsberger H, Nehele T, Spelsberg F, Bauchinger M, et al. Cytogenetic and molecular genetic characterisation of a chromosome 2 rearrangement in a case of human papillary thyroid carcinoma with radiation history. Cancer Genet Cytogenet 1997;96:30-6.
19. du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Dohner H, et al. Detection of complete and partial chromosome gains and losses by comparative genomic hybridization. Hum Genet 1993;90:590-610.
20. Johnson GD, Nogueira Araujo GM. A simple method of reducing the fading of immunofluorescence during microscopy. Immunol Methods 1981;43:349-50.
21. Sheperd JC, Fried RA. Preventing cervical cancer: the role of the Bethesda system. Am Fam Physician 1995;51:434-40.
22. Shafi MI, Luesley DM. Management of low grade lesions: follow-up or treat? Baillieres Clin Obstet Gynaecol 1995;9: 121-31.